<DOC>
	<DOCNO>NCT00747812</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness implantable device treat migraine . There significant number patient drug refractory migraine alternative therapy need .</brief_summary>
	<brief_title>Study Occipital Nerve Stimulation Drug Refractory Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Be diagnose multiple migraine per month moderate severe intensity ; Be refractory medication ; Be appropriate candidate surgical procedure require fo study ; Be willing able comply study related procedure ; Be capable read understanding patient information material give write informed consent . Have onset headache age 50 ; Are current substance abuser ( include alcohol illicit drug ) ; Have significant psychiatric disorder ; Have previously treat occipital nerve stimulation ( either temporary trial permanent implant ) ; Have nerve stimulation pain relief . Have injection botulinum toxin head neck within 6 month prior enrollment ; Have previously undergone destructive ganglionectomy affect C2/C3 occipital and/or trigeminal distribution occipital blockade radiofrequency procedure currently effect . Have condition currently require likely require use MRI diathermy ; Have active implantable device ; Are pregnant lactate plan become pregnant next 14 month ; Have participate drug device trial last 4 week plant participate study next 14 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Headache</keyword>
	<keyword>Migraine</keyword>
	<keyword>Refractory</keyword>
	<keyword>Chronic</keyword>
	<keyword>Pain</keyword>
</DOC>